<DOC>
	<DOC>NCT01145950</DOC>
	<brief_summary>To compare the pharmacokinetic characteristic of LBEC0101 25mg with the active comparator, Enbrel® 25 mg.</brief_summary>
	<brief_title>Study to Compare the Safety and Pharmacokinetic Characteristics of LBEC0101 25 mg With Those of Enbrel®</brief_title>
	<detailed_description />
	<mesh_term>Etanercept</mesh_term>
	<criteria>Healthy males, 20 to 45 years of age the moment of screening Body mass index is between 18.0 and 30.0 kg/m The tuberculosis patient or latent tuberculosis patient Hypersensitivity response to the test and comparator drugs</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>Etanercept</keyword>
	<keyword>Enbrel</keyword>
	<keyword>healthy volunteers</keyword>
</DOC>